Cargando…

Targeted in vitro gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework

Chikungunya fever caused by the mosquito-transmitted chikungunya virus (CHIKV) is a major public health concern in tropical, sub-tropical and temperate climatic regions. The lack of any licensed vaccine or antiviral agents against CHIKV warrants the development of effective antiviral therapies. Smal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tagore, Rajarshee, Alagarasu, Kalichamy, Patil, Poonam, Pyreddy, Suneela, Polash, Shakil Ahmed, Kakade, Mahadeo, Shukla, Ravi, Parashar, Deepti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Bioengineering and Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806579/ https://www.ncbi.nlm.nih.gov/pubmed/36601387 http://dx.doi.org/10.3389/fbioe.2022.1003448

Ejemplares similares

Amino Acid-Coated Zeolitic Imidazolate Framework for Delivery of Genetic Material in Prostate Cancer Cell
por: Polash, Shakil Ahmed, et al.
Publicado: (2023)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses
por: Alagarasu, Kalichamy, et al.
Publicado: (2022)

A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2
por: Punekar, Madhura, et al.
Publicado: (2022)

A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
por: Poddar, A., et al.
Publicado: (2022)

Studies on the antiviral activity of chebulinic acid against dengue and chikungunya viruses and in silico investigation of its mechanism of inhibition
por: Thomas, Naiju, et al.
Publicado: (2022)

Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2
por: Panda, Kingshuk, et al.
Publicado: (2021)

Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity
por: Kumar, Sameer, et al.
Publicado: (2018)

Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication
por: Panda, Kingshuk, et al.
Publicado: (2021)

In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus
por: Patil, Poonam, et al.
Publicado: (2021)

Decadal Change in Seroprevalence of Chikungunya Virus Infection in Pune City, India
por: Tomar, Shilpa Jagatram, et al.
Publicado: (2022)

Antiviral & platelet-protective properties of Carica papaya in dengue
por: Shrivastava, Nidhi, et al.
Publicado: (2022)

Expression and biochemical characterization of nsP2 cysteine protease of Chikungunya virus
por: Pastorino, Boris A.M., et al.
Publicado: (2008)

Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity
por: Mathur, Kalika, et al.
Publicado: (2016)

NTPase and 5′-RNA Triphosphatase Activities of Chikungunya Virus nsP2 Protein
por: Karpe, Yogesh A., et al.
Publicado: (2011)

Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus
por: Nguyen, Phuong T. V., et al.
Publicado: (2014)

1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors
por: Ivanova, Larisa, et al.
Publicado: (2021)

A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2019)

Anti-Dengue Activity of Lipophilic Fraction of Ocimum basilicum L. Stem
por: Joshi, Rajesh Kumar, et al.
Publicado: (2023)

In-vitro antiviral activity of Carica papaya formulations against dengue virus type 2 and chikungunya virus
por: Patil, P., et al.
Publicado: (2022)

Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores
por: Jones, Rhian, et al.
Publicado: (2023)

Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Expression of Plasmid-Based shRNA against the E1 and nsP1 Genes Effectively Silenced Chikungunya Virus Replication
por: Lam, Shirley, et al.
Publicado: (2012)

In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2)
por: Panda, Kingshuk, et al.
Publicado: (2021)

Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors
por: Agarwal, T., et al.
Publicado: (2015)

Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus
por: Fros, Jelke J., et al.
Publicado: (2015)

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection
por: Delang, L., et al.
Publicado: (2016)

Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design
por: Zhang, Sixue, et al.
Publicado: (2021)

Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes
por: Göertz, Giel P., et al.
Publicado: (2018)

Evaluation of the Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular Modeling with nsP3 Protein of Chikungunya Virus (CHIKV)
por: Puranik, Ninad V., et al.
Publicado: (2019)

Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4
por: Martins, Daniel Oliveira Silva, et al.
Publicado: (2022)

A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme
por: Bullard-Feibelman, Kristen M., et al.
Publicado: (2016)

Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication
por: Krieg, Sarah, et al.
Publicado: (2023)

TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients
por: Alagarasu, Kalichamy, et al.
Publicado: (2021)

Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness
por: Mounce, Bryan C., et al.
Publicado: (2017)

Sindbis Virus nsP2 Endopeptidase
por: Strauss, Ellen G., et al.
Publicado: (2013)

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Cell-Type-Dependent Role for nsP3 Macrodomain ADP-Ribose Binding and Hydrolase Activity during Chikungunya Virus Infection
por: Kim, Taewoo, et al.
Publicado: (2022)

Antiviral Perspectives for Chikungunya Virus
por: Parashar, Deepti, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mou4f2rij70r7fpk238bdu7hln